^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
A-337
i
Other names: A-337
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
ITabMed
Drug class:
CD3 agonist, EPCAM inhibitor
Related drugs:
1year
An Exploratory Study of A-337 in the Management of Malignant Solid Dose Escalation and Expansion Phases (clinicaltrials.gov)
P1, N=94, Not yet recruiting, ITabMed Co., Ltd.
New P1 trial
|
A-337
Share via
